• Please be aware we've switched the forums to their own URL. (again) You'll find the new website address to be www.steelernationforum.com Thanks
  • Please clear your private messages. Your inbox is close to being full.

Covid Vaccine

but, wait... there's moar!

 
Badcat said:
Jimmy Dore exposing that the Influenza vaccine issued last year didn't protect the recipient at all and in fact, made people more likely to get the flu.

Click to expand...

At least you just get a 27% higher chance to get the flu......much better than myocarditis roulette or failed pregnacies.
 
 
The latest Rasmussen Reports national telephone and online survey finds that 51% of American Adults believe it’s likely that the COVID-19 vaccine has caused inflammation in the hearts of many vaccinated Americans, including 29% who think it is Very Likely. Twenty-eight percent (28%) don’t consider it likely that COVID-19 vaccine caused many cases of heart inflammation, and 21% are not sure.
 
51% of vaccinated people don't believe there is any inflammation of their hearts. 9% of vaccinated people are not sure. The other 40% of vaccinated people are dead.
 
Yet another post-pandemic study validating what we've been saying for 4 years.

Review
Myocarditis after SARS-CoV-2 infection and COVID-19 vaccination: Epidemiology, outcomes, and new perspectives

ABSTRACT​

Myocarditis, typically manifesting as myopericarditis, is among the serious cardiac consequences observed over the course of the COVID-19 pandemic. We performed a comprehensive, evidence-based literature synthesis of findings from clinical trial data reanalyses, post-marketing surveillance, large observational studies, and other diverse research sources that help shed light on the phenomenon of myocarditis post SARS-CoV-2 infection versus COVID-19 vaccine-induced myocarditis. Our conclusions refute several claims previously made by public health agencies and professional associations, namely the following: (1) the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Omicron infections have caused more cases of myocarditis than the COVID-19 mRNA immunizations; (2) mRNA vaccine-induced myocarditis is typically mild, transient, and rare, with no long-term sequelae; and (3) the risk-benefit calculus favors continued use of these products despite evidence of more iatrogenic cases. We address each of these misconceptions by applying a combination of epidemiological, clinical, and immunological perspectives. We urge governments to remove the COVID-19 mRNA products from the market due to the well-documented risk of myocardial damage, a risk that is strongest for younger males (<40 years old).

Full Study:
Myo.jpg

Various sources of epidemiological and clinical data collectively highlight an emerging pattern suggesting that the risks of myopericarditis (either specifically defined myocarditis or pericarditis or most often both conditions) associated with COVID-19 vaccination were significantly underreported and/ or underestimated by regulatory agencies due to the lack of large-scale prospective cohort studies with baseline and post vaccination assessments (history, ECG, laboratories, cardiac imaging).
Click to expand...

The claim that SARS-CoV-2 infection causes more myocarditis than the COVID-19 mRNA vaccines lacks robust evidence and is largely based on biased and flawed research methodologies. As discussed earlier, reliance on ICD-10 coding and troponin levels in hospitalized patients has led to widespread misclassification of infection-related myocarditis. Autopsy studies of fatal COVID-19 cases have failed to detect direct viral damage to the heart, further challenging the accuracy of these diagnoses.
Click to expand...

The combination of low risk of severe COVID-19 and a higher likelihood of mRNA vaccine-related myocarditis in younger people makes it difficult to rationalize a policy of ongoing mRNA vaccines in this population.
Click to expand...

The theoretical absolute benefit of COVID-19 mRNA vaccination is largely contingent on an individual’s baseline risk of severe COVID-19 disease, prior natural immunity, current SARS-CoV-2 and access to early ambulatory treatment protocols. For healthy individuals under the age of 20, 30, or 40, the upper bound of absolute benefits has consistently been negligible across all strains, often approaching zero. Furthermore, no robust studies to date have reliably established a benefit of the COVID-19 vaccination in infants, children and young adults. Even relatively rare safety signals (on a population-wide basis) can substantially alter the overal risk-benefit analysis in younger populations.
Click to expand...
 
Still don't regret not taking it (or any vax).
 
You must log in or register to reply here.
Top